Dermatol. praxi. 2017;11(1):39-42 | DOI: 10.36290/der.2017.009

Hydroquinone and tretinoin – new substances for extemporaneous preparation

Mgr. Lukáš Láznička, PharmDr. Veronika Bucharová
Nemocniční lékárna Fakultní nemocnice Královské Vinohrady

Hydroquinone and tretinoin are newly available substances for extemporaneous preparation. Thanks to them is possible to prepare

creams for treating skin hyperpigmenation. Formulas containing tretinoin can replace unavailable medicinal products, choose

a different concentration of the drug or to prepare other dosage forms, which are not available in registered medicinal products.

Keywords: hyperpigmentation, hydroquinone, tretinoin, acne

Published: April 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Láznička L, Bucharová V. Hydroquinone and tretinoin – new substances for extemporaneous preparation. Dermatol. praxi. 2017;11(1):39-42. doi: 10.36290/der.2017.009.
Download citation

References

  1. Deutscher Arzneimittel-Codex 2015/Neues Rezeptur-Formularium. Band I-III. Pharmazeutischen Laboratorium des NRF. Eschborn: Govi-Verlag und Stuttgart: Deutscher Apotheker-Verlag, 2015.
  2. Bienová M, Kučerová R. Hyperpigmentace u žen středního věku. Med. Pro Praxi 2007; 2: 80-82.
  3. Ebanks JP, Wickett RR, Boissy RE. Mechanisms Regulating Skin Pigmentation: The Rise and Fall of Complexion Coloration. Int. J. Mol. Sci. 2009; 10(9): 4066-4087. Go to original source... Go to PubMed...
  4. Slíva J, Minárik J. Doplňky stravy. Vyd. 1. Praha: Triton, 2009.
  5. Rozhodnutí MZČR o povelní používání hydrochinonu pro humánní použití; Č. j. MZDR 71614/2015/FAR ze dne 9. 12. 2015.
  6. Enguita FJ, Leitao AL. Hydroquinone: Environmental Pollution, Toxicity, and Microbial Answers. DOI: 10.1155/2013/542168.
  7. IARC Publications. Hydroquinone. Monographs.https://monographs.iarc.fr/ENG/ Monographs/ vol71/mono71-30. pdf [cit. 2016-10-10].
  8. Loft S, Denq XS, Tuo J, et al. Experimental study of oxidative DNA damage. Free Radic.Res. 1998; 29: 525-539. Go to original source... Go to PubMed...
  9. Bollati V, Baccarelli A, Hou L, et al. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res. 2007; 67: 876-880. Go to original source... Go to PubMed...
  10. Mehlman MA. Dangerous and cancer-causing properties of products and chemicals in the oil refining and petrochemical industries. Part XXX: Causal relationship between chronic myelogenous leukemia and benzene-containing solvents. Ann. N.Y. Acad. Sci. 2006; 1076: 110-119. Go to original source... Go to PubMed...
  11. Formularium der Nederlandse apothekers. Vijfde herziene druk. Den Haag: Koninklijke Nederlandse Maatschappij ter Bevordering der Pharmacie, 2013.
  12. Globale dermatologie http://www.globale-dermatologie.com/hydrochinon-deutsch.html#.V_ombOWLQdV [cit. 2016-10-10].
  13. Gold M, Rendon M, Dibernardo B, Bruce S, Lucas-Anthony Ch, Watson J. Open-Label Treatment of Moderate or Marked Melasma with a 4% Hydroquinone Skin Care System Plus 0.05% Tretinoin Cream. J Clin Aesthet Dermatol. 2013; 6(11): 32-38.
  14. Rendon M, Dryer L. Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and Photodamage. J Drugs Dermatol. 2016; 15(4): 466-475. Go to PubMed...
  15. Bienová M, Kučerová R. Retinoidy v dermatologii. Dermatol. praxi 2008; 2(4): 171-174.
  16. Shin HS, Won CH, Lee SH, Kwon OS, Kim KH, Eun HC. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial. Am J Clin Dermatol. 2007; 8(5): 285-290. Go to original source... Go to PubMed...
  17. Český lékopis 2009. 1. vyd. Praha: Grada Publishing, 2009.
  18. Binová M, Ditrichová D. Léze v dutině ústní. Med. Pro Praxi 2010; 7(11): 439-442.
  19. Klauzová K. Poruchy pigmentace - melazma a jeho léčba. Prakt. lékáren. 2010; 6(4): 177-181.




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.